Skip to main content

Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program

Sesame is offering compounded semaglutide — the active ingredient in Wegovy and Ozempic — to help users access obesity and diabetes treatments amid shortages.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.